Literature DB >> 25283840

The Krüppel-like factor 2 transcription factor gene is recurrently mutated in splenic marginal zone lymphoma.

R Piva1, S Deaglio2, R Famà3, R Buonincontri2, I Scarfò1, A Bruscaggin3, E Mereu1, S Serra2, V Spina3, D Brusa2, G Garaffo1, S Monti3, M Dal Bo4, R Marasca5, L Arcaini6, A Neri7, V Gattei4, M Paulli8, E Tiacci9, F Bertoni10, S A Pileri11, R Foà12, G Inghirami13, G Gaidano3, D Rossi3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25283840     DOI： 10.1038/leu.2014.294

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  14 in total

1.  Krüppel-like factor 2 (KLF2) regulates B-cell reactivity, subset differentiation, and trafficking molecule expression.

Authors:  Geoffrey T Hart; Xiaodan Wang; Kristin A Hogquist; Stephen C Jameson
Journal:  Proc Natl Acad Sci U S A       Date:  2010-12-27       Impact factor: 11.205

2.  B cell homeostasis and plasma cell homing controlled by Krüppel-like factor 2.

Authors:  Rebecca Winkelmann; Lena Sandrock; Martina Porstner; Edith Roth; Martina Mathews; Elias Hobeika; Michael Reth; Mark L Kahn; Wolfgang Schuh; Hans-Martin Jäck
Journal:  Proc Natl Acad Sci U S A       Date:  2010-12-27       Impact factor: 11.205

Review 3.  Krüppel-like factors: three fingers in control.

Authors:  Shivalingappa K Swamynathan
Journal:  Hum Genomics       Date:  2010-04       Impact factor: 4.639

4.  KLF2 inhibits Jurkat T leukemia cell growth via upregulation of cyclin-dependent kinase inhibitor p21WAF1/CIP1.

Authors:  Jinghai Wu; Jerry B Lingrel
Journal:  Oncogene       Date:  2004-10-21       Impact factor: 9.867

5.  Whole-genome sequencing identifies recurrent somatic NOTCH2 mutations in splenic marginal zone lymphoma.

Authors:  Mark J Kiel; Thirunavukkarasu Velusamy; Bryan L Betz; Lili Zhao; Helmut G Weigelin; Mark Y Chiang; David R Huebner-Chan; Nathanael G Bailey; David T Yang; Govind Bhagat; Roberto N Miranda; David W Bahler; L Jeffrey Medeiros; Megan S Lim; Kojo S J Elenitoba-Johnson
Journal:  J Exp Med       Date:  2012-08-13       Impact factor: 14.307

6.  The coding genome of splenic marginal zone lymphoma: activation of NOTCH2 and other pathways regulating marginal zone development.

Authors:  Davide Rossi; Vladimir Trifonov; Marco Fangazio; Alessio Bruscaggin; Silvia Rasi; Valeria Spina; Sara Monti; Tiziana Vaisitti; Francesca Arruga; Rosella Famà; Carmela Ciardullo; Mariangela Greco; Stefania Cresta; Daniela Piranda; Antony Holmes; Giulia Fabbri; Monica Messina; Andrea Rinaldi; Jiguang Wang; Claudio Agostinelli; Pier Paolo Piccaluga; Marco Lucioni; Fabrizio Tabbò; Roberto Serra; Silvia Franceschetti; Clara Deambrogi; Giulia Daniele; Valter Gattei; Roberto Marasca; Fabio Facchetti; Luca Arcaini; Giorgio Inghirami; Francesco Bertoni; Stefano A Pileri; Silvia Deaglio; Robin Foà; Riccardo Dalla-Favera; Laura Pasqualucci; Raul Rabadan; Gianluca Gaidano
Journal:  J Exp Med       Date:  2012-08-13       Impact factor: 14.307

7.  Silencing of Kruppel-like factor 2 by the histone methyltransferase EZH2 in human cancer.

Authors:  H Taniguchi; F V Jacinto; A Villanueva; A F Fernandez; H Yamamoto; F J Carmona; S Puertas; V E Marquez; Y Shinomura; K Imai; M Esteller
Journal:  Oncogene       Date:  2011-09-05       Impact factor: 9.867

8.  Analysis of the coding genome of diffuse large B-cell lymphoma.

Authors:  Laura Pasqualucci; Vladimir Trifonov; Giulia Fabbri; Jing Ma; Davide Rossi; Annalisa Chiarenza; Victoria A Wells; Adina Grunn; Monica Messina; Oliver Elliot; Joseph Chan; Govind Bhagat; Amy Chadburn; Gianluca Gaidano; Charles G Mullighan; Raul Rabadan; Riccardo Dalla-Favera
Journal:  Nat Genet       Date:  2011-07-31       Impact factor: 38.330

9.  Whole-exome sequencing in splenic marginal zone lymphoma reveals mutations in genes involved in marginal zone differentiation.

Authors:  N Martínez; C Almaraz; J P Vaqué; I Varela; S Derdak; S Beltran; M Mollejo; Y Campos-Martin; L Agueda; A Rinaldi; I Kwee; M Gut; J Blanc; D Oscier; J C Strefford; J Martinez-Lopez; A Salar; F Sole; J L Rodriguez-Peralto; C Diez-Tascón; J F García; M Fraga; E Sebastián; J Alvés; J Menárguez; J González-Carreró; L F Casado; M Bayes; F Bertoni; I Gut; M A Piris
Journal:  Leukemia       Date:  2013-12-03       Impact factor: 11.528

10.  Whole exome sequencing identifies novel recurrently mutated genes in patients with splenic marginal zone lymphoma.

Authors:  Marina Parry; Matthew J J Rose-Zerilli; Jane Gibson; Sarah Ennis; Renata Walewska; Jade Forster; Helen Parker; Zadie Davis; Anne Gardiner; Andrew Collins; David G Oscier; Jonathan C Strefford
Journal:  PLoS One       Date:  2013-12-13       Impact factor: 3.240
View more
  30 in total

1.  Clinical and diagnostic relevance of NOTCH2-and KLF2-mutations in splenic marginal zone lymphoma.

Authors:  Yolanda Campos-Martín; Nerea Martínez; Azahara Martínez-López; Laura Cereceda; Felipe Casado; Patrocinio Algara; David Oscier; Francisco J Menarguez; Juan F García; Miguel A Piris; Manuela Mollejo
Journal:  Haematologica       Date:  2017-05-18       Impact factor: 9.941

2.  CBL-MZ is not a single biological entity: evidence from genomic analysis and prolonged clinical follow-up.

Authors:  Helen Parker; Neil Robert McIver-Brown; Zadie A Davis; Marina Parry; Matthew J J Rose-Zerilli; Aliki Xochelli; Jane Gibson; Renata Walewska; Jonathan C Strefford; David G Oscier
Journal:  Blood Adv       Date:  2018-05-22

Review 3.  Clinical utility of recently identified diagnostic, prognostic, and predictive molecular biomarkers in mature B-cell neoplasms.

Authors:  Arantza Onaindia; L Jeffrey Medeiros; Keyur P Patel
Journal:  Mod Pathol       Date:  2017-06-30       Impact factor: 7.842

Review 4.  Clinical impact of recurrently mutated genes on lymphoma diagnostics: state-of-the-art and beyond.

Authors:  Richard Rosenquist; Andreas Rosenwald; Ming-Qing Du; Gianluca Gaidano; Patricia Groenen; Andrew Wotherspoon; Paolo Ghia; Philippe Gaulard; Elias Campo; Kostas Stamatopoulos
Journal:  Haematologica       Date:  2016-09       Impact factor: 9.941

5.  Differences between BCL2-break positive and negative follicular lymphoma unraveled by whole-exome sequencing.

Authors:  A Zamò; J Pischimarov; M Schlesner; P Rosenstiel; R Bomben; H Horn; T Grieb; T Nedeva; C López; A Haake; J Richter; L Trümper; C Lawerenz; W Klapper; P Möller; M Hummel; D Lenze; M Szczepanowski; L Flossbach; M Schreder; V Gattei; G Ott; R Siebert; A Rosenwald; E Leich
Journal:  Leukemia       Date:  2017-08-21       Impact factor: 11.528

Review 6.  Marginal Zone Lymphoma: Clinicopathologic Variations and Approaches to Therapy.

Authors:  Sabarish Ayyappan; Basem M William
Journal:  Curr Oncol Rep       Date:  2018-03-23       Impact factor: 5.075

7.  TLR-mediated activation of Waldenström macroglobulinemia B cells reveals an uncoupling from plasma cell differentiation.

Authors:  Jennifer Shrimpton; Matthew A Care; Jonathan Carmichael; Kieran Walker; Paul Evans; Charlotte Evans; Ruth de Tute; Roger Owen; Reuben M Tooze; Gina M Doody
Journal:  Blood Adv       Date:  2020-06-23

8.  Genetic landscape of hepatitis B virus-associated diffuse large B-cell lymphoma.

Authors:  Weicheng Ren; Xiaofei Ye; Hong Su; Wei Li; Dongbing Liu; Mohammad Pirmoradian; Xianhuo Wang; Bo Zhang; Qiang Zhang; Longyun Chen; Man Nie; Yao Liu; Bin Meng; Huiqiang Huang; Wenqi Jiang; Yixin Zeng; Wenyu Li; Kui Wu; Yong Hou; Klas G Wiman; Zhiming Li; Huilai Zhang; Roujun Peng; Shida Zhu; Qiang Pan-Hammarström
Journal:  Blood       Date:  2018-03-15       Impact factor: 22.113

9.  The genetics of nodal marginal zone lymphoma.

Authors:  Valeria Spina; Hossein Khiabanian; Monica Messina; Sara Monti; Luciano Cascione; Alessio Bruscaggin; Elisa Spaccarotella; Antony B Holmes; Luca Arcaini; Marco Lucioni; Fabrizio Tabbò; Sakellarios Zairis; Fary Diop; Michaela Cerri; Sabina Chiaretti; Roberto Marasca; Maurilio Ponzoni; Silvia Deaglio; Antonio Ramponi; Enrico Tiacci; Laura Pasqualucci; Marco Paulli; Brunangelo Falini; Giorgio Inghirami; Francesco Bertoni; Robin Foà; Raul Rabadan; Gianluca Gaidano; Davide Rossi
Journal:  Blood       Date:  2016-06-22       Impact factor: 22.113

10.  Deregulated KLF4 Expression in Myeloid Leukemias Alters Cell Proliferation and Differentiation through MicroRNA and Gene Targets.

Authors:  Valerie A Morris; Carrie L Cummings; Brendan Korb; Sean Boaglio; Vivian G Oehler
Journal:  Mol Cell Biol       Date:  2015-12-07       Impact factor: 4.272
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.